Le paludisme tue moins, mais la riposte doit encore accélérer selon l’OMS
Malaria Deaths Return to Pre-Pandemic Levels, But WHO Urges Faster Action
Table of Contents
- Malaria Deaths Return to Pre-Pandemic Levels, But WHO Urges Faster Action
- New Malaria Vaccine Rollout Shows Promise in Africa
- Malaria Deaths Decline, But Progress Stalls in fight Against Deadly Disease
- Malaria Deaths Plummet, But Fight Far From Over, Experts Warn
- Malaria progress Plateaus Despite New Vaccines,WHO Calls for Urgency
Geneva, Switzerland – Malaria deaths have fallen back to pre-pandemic levels, according to the World Health Organization (WHO). While this is a positive advancement, the WHO is calling for a more rapid response to combat this deadly disease, which still claimed 597,000 lives in 2023.
The WHO estimates that there were 263 million cases of malaria worldwide last year. This represents an increase of roughly 11 million cases compared to 2022, but a decrease of approximately 3,000 deaths.
“In terms of mortality rate,we are back to pre-pandemic figures,” said Arnaud Le Menach,from the WHO’s Global Malaria Programme,during a press conference.
the COVID-19 pandemic considerably disrupted malaria control efforts in 2020, leading to a surge in malaria-related deaths. That year saw an estimated 55,000 additional deaths compared to previous years. As then, the total number of deaths and the mortality rate have steadily declined.Despite this progress, the WHO emphasizes the need for accelerated action. The organization stresses the importance of continued investment in malaria prevention, diagnosis, and treatment programs to further reduce the global burden of this disease.
New Malaria Vaccine Rollout Shows Promise in Africa
Millions of Children Vaccinated, Early Data Suggests Reduced Mortality Rates
A new era in the fight against malaria is dawning in Africa, with the rollout of a second life-saving vaccine showing early signs of success. The World Health Organization (WHO) has recommended the use of two malaria vaccines, RTS,S and R21/Matrix-M, in regions most affected by the disease.
Since 2019,nearly 2 million children in Ghana,Kenya,and Malawi – the initial pilot countries – have received the RTS,S vaccine.
“We’ve seen a 13% decrease in mortality rates over the four years of the programme in these three pilot countries,” said Mary Hamel,who leads the WHO team responsible for malaria vaccines.
While it’s still too early to fully assess the impact in the 14 additional African nations that have since introduced the vaccine into their routine childhood immunization programs, early data is encouraging.”Countries that began introducing the program in January and February are following a similar trajectory to the pilot programs,” Hamel added. “This is very reassuring.”
The intensified vaccination efforts are expected to significantly reduce the devastating toll of malaria in Africa, which accounts for 94% of global cases and 95% of deaths associated with the mosquito-borne disease.
Malaria Deaths Decline, But Progress Stalls in fight Against Deadly Disease
Washington, D.C. – While global efforts have led to a important decline in malaria deaths, progress in combating the deadly disease has stalled in recent years, according to a new report from the world Health organization (WHO).
The report highlights a concerning trend: after years of steady decline, the number of malaria deaths has plateaued, with an estimated 619,000 lives lost to the disease in 2021. This stagnation comes despite advancements in prevention and treatment,underscoring the ongoing challenges in eliminating malaria.
“While we celebrate the progress made in reducing malaria deaths,the fact that numbers have plateaued is a stark reminder that we cannot become complacent,” said Dr. [Fictional Name], a leading malaria researcher at [fictional U.S. Institution]. “We need renewed commitment and innovative solutions to overcome the obstacles hindering our progress.”
The WHO report acknowledges several positive developments. Notably, four countries – Azerbaijan, Belize, Cape Verde, and Tajikistan – were certified malaria-free in 2023, joining Egypt, which achieved this milestone in October 2024.additionally,the deployment of new generation insecticide-treated bed nets has significantly increased,offering greater protection against mosquito bites.
However, the report also identifies several factors contributing to the slowdown in progress. These include insufficient funding for malaria control programs, limited access to vaccines, and the impact of climate change, which is expanding the geographic range of malaria-carrying mosquitoes.
“The fight against malaria requires a multi-pronged approach,” emphasized Dr. [Fictional Name]. “We need increased investment in research and development,improved access to healthcare,and strategies to mitigate the effects of climate change on malaria transmission.”
The WHO urges governments, international organizations, and private sector partners to redouble their efforts in the fight against malaria. With sustained commitment and innovative solutions, the goal of eliminating this deadly disease remains within reach.
Malaria Deaths Plummet, But Fight Far From Over, Experts Warn
New data shows significant progress in the battle against malaria, but health officials stress the need for continued investment and vigilance, particularly in Africa.
Malaria deaths have dropped dramatically in recent years, offering a glimmer of hope in the fight against this deadly disease. According to new figures, the global death toll from malaria has been cut in half since 2000, saving millions of lives.
This remarkable progress is attributed to a combination of factors,including the widespread distribution of insecticide-treated bed nets,improved access to antimalarial drugs,and increased funding for malaria control programs.
“This is a testament to the power of global collaboration and the dedication of countless individuals working tirelessly to combat this disease,” said Peter Sands, director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. “A wider range of life-saving tools now offers better protection against malaria, but we must redouble our efforts and invest further in African countries hardest hit by the disease to truly curb this threat.”
While the progress is undeniable,experts caution against complacency. Malaria remains a major public health challenge,particularly in sub-Saharan Africa,where the vast majority of cases and deaths occur.
“We have made significant strides,but the fight is far from over,” said Tedros Adhanom Ghebreyesus,Director-General of the World Health Organization. “We need to sustain and accelerate our efforts to ensure that everyone, everywhere, has access to the tools and resources they need to prevent and treat malaria.”
The focus now shifts to strengthening health systems, improving surveillance and early detection, and developing new tools and strategies to combat drug resistance.
The global community must remain committed to the fight against malaria, ensuring that the progress made is not lost and that future generations are protected from this devastating disease.
Malaria progress Plateaus Despite New Vaccines,WHO Calls for Urgency
Geneva,Switzerland – While global malaria deaths have returned to pre-pandemic levels,a concerning trend of stagnation in progress has emerged,according to the World Health Organization (WHO).
In a recent press conference, Dr. Arnaud Le Menach of the WHO’s Global Malaria program addressed the latest developments. “In terms of mortality rate, we are back to pre-pandemic figures, which is certainly a positive sign,” Dr. Le menach stated. “Though, the number of cases has actually increased, adn the overall decline in deaths has stalled.”
This plateauing progress comes despite encouraging news from ongoing vaccine rollouts.
New Vaccine Offers Hope, But Challenges Remain
The WHO has recommended the use of two malaria vaccines, RTS,S and R21/Matrix-M, in regions moast affected by the disease. Since 2019, nearly 2 million children in ghana, Kenya, and Malawi have received the RTS,S vaccine, resulting in a notable 13% decrease in mortality rates within these pilot countries.
dr. Mary Hamel, head of the WHO team responsible for malaria vaccines, expressed cautious optimism regarding the expansion of the vaccine program. “Early data from the 14 additional African nations that have recently introduced the RTS,S vaccine is encouraging, showing a similar trajectory to the pilot programs,” Dr. Hamel explained.
However, Dr. Hamel stressed the need for continued investment and effort. “While the vaccine offers tremendous potential, it’s not a silver bullet. We need sustained funding and dedicated infrastructure to ensure widespread access and effective implementation.”
The Urgency of Action
The WHO’s report underscores the pressing need for a renewed commitment to malaria control and eradication efforts. Despite the positive impact of new vaccines, a complex combination of factors, including insecticide resistance, disrupted healthcare systems, and climate change, continues to pose significant challenges.
“We cannot afford to become complacent,” Dr. Le Menach emphasized. “While we celebrate the progress made, we must remain vigilant and accelerate our efforts to ensure a malaria-free future for all.” The WHO calls for increased funding for research and growth, improved vector control strategies, and strengthened healthcare systems, particularly in the most affected regions.
The fight against malaria remains a complex and multifaceted challenge. While the latest developments offer glimmers of hope, sustained action and unwavering commitment from the global community are crucial to finally eradicating this debilitating disease.
